과제정보
This study was supported by Green Cross Corp. and by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI16C0992).
참고문헌
- Rhim JW, Kim KH, Kim DS, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci 2012;27:788-793. https://doi.org/10.3346/jkms.2012.27.7.788
- Carneiro-Sampaio M, Moraes-Vasconcelos D, Kokron CM, et al. Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol 2013;33:716-724. https://doi.org/10.1007/s10875-013-9865-6
- Gathmann B, Mahlaoui N; CEREDIH, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014;134:116-126. https://doi.org/10.1016/j.jaci.2013.12.1077
- Kim JH, Park HJ, Choi GS, et al. Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort. J Korean Med Sci 2010;25:824-828. https://doi.org/10.3346/jkms.2010.25.6.824
- Kim JH, Ye YM, Ban GY, et al. Effects of immunoglobulin replacement on asthma exacerbation in adult asthmatics with IgG subclass deficiency. Allergy Asthma Immunol Res 2017;9:526-533. https://doi.org/10.4168/aair.2017.9.6.526
- Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343-373. https://doi.org/10.1183/09031936.00202013
- Modell V, Gee B, Lewis DB, et al. Global study of primary immunodeficiency diseases (PI): diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res 2011;51:61-70. https://doi.org/10.1007/s12026-011-8241-y
- Lee WI, Huang JL, Jaing TH, et al. Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985-2010. Immunobiology 2011;216:1286-1294. https://doi.org/10.1016/j.imbio.2011.06.002
- Takada H. Primary immunodeficiency in Japan: epidemiology, diagnosis, and pathogenesis. Pediatr Int 2013;55:671-674. https://doi.org/10.1111/ped.12224
- Lim DL, Thong BY, Ho SY, et al. Primary immunodeficiency diseases in Singapore: the last 11 years. Singapore Med J 2003;44:579-586.
- Mahlaoui N, Jais JP, Brosselin P, et al. Prevalence of primary immunodeficiencies in France is underestimated. J Allergy Clin Immunol 2017;140:1731-1733. https://doi.org/10.1016/j.jaci.2017.06.020
- Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci 2012;1250:62-72. https://doi.org/10.1111/j.1749-6632.2011.06289.x
- Kilic SS, Ozel M, Hafizoglu D, Karaca NE, Aksu G, Kutukculer N. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey: two centers study. J Clin Immunol 2013;33:74-83. https://doi.org/10.1007/s10875-012-9763-3
- Ulambayar B, Lee SH, Yang EM, Ye YM, Park HS. Association between epithelial cytokines and clinical phenotypes of elderly asthma. Allergy Asthma Immunol Res 2019;11:79-89. https://doi.org/10.4168/aair.2019.11.1.79
- Ban GY, Ye YM, Kim SH, et al. Plasma LTE4/PGF2α ratio and blood eosinophil count are increased in elderly asthmatics with previous asthma exacerbation. Allergy Asthma Immunol Res 2017;9:378-382. https://doi.org/10.4168/aair.2017.9.4.378
- Eder W, Ege MJ, von Mutius E. The asthma epidemic N Engl J Med 2006;355:2226-2235. https://doi.org/10.1056/NEJMra054308
- Song WJ, Kang MG, Chang YS, Cho SH. Epidemiology of adult asthma in Asia: toward a better understanding. Asia Pac Allergy 2014;4:75-85. https://doi.org/10.5415/apallergy.2014.4.2.75
- Gupta S, Agrawal A, Agrawal S, Su H, Gollapudi S. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun Ageing 2006;3:5. https://doi.org/10.1186/1742-4933-3-5
- Listi F, Candore G, Modica MA, et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci 2006;1089:487-495. https://doi.org/10.1196/annals.1386.013
- Weksler ME. Changes in the B-cell repertoire with age. Vaccine 2000;18:1624-1628. https://doi.org/10.1016/S0264-410X(99)00497-1
- Radl J, Sepers JM, Skvaril F, Morell A, Hijmans W. Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol 1975;22:84-90.
- Abdou NI, Greenwell CA, Mehta R, Narra M, Hester JD, Halsey JF. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults. Int Arch Allergy Immunol 2009;149:267-274. https://doi.org/10.1159/000199723
- Abrahamian F, Agrawal S, Gupta S. Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy. Clin Exp Immunol 2010;159:344-350. https://doi.org/10.1111/j.1365-2249.2009.04062.x
- Rich AL, Le Jeune IR, McDermott L, Kinnear WJ. Serial lung function tests in primary immune deficiency. Clin Exp Immunol 2008;151:110-113. https://doi.org/10.1111/j.1365-2249.2007.03550.x
- Verma N, Grimbacher B, Hurst JR. Lung disease in primary antibody deficiency. Lancet Respir Med 2015;3:651-660. https://doi.org/10.1016/S2213-2600(15)00202-7
- Kaveri SV, Maddur MS, Hegde P, Lacroix-Desmazes S, Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol 2011;164:2-5. https://doi.org/10.1111/j.1365-2249.2011.04387.x
- Albin S, Cunningham-Rundles C. An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. Immunotherapy 2014;6:1113-1126. https://doi.org/10.2217/imt.14.67
- Quinti I, Soresina A, Guerra A, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011;31:315-322. https://doi.org/10.1007/s10875-011-9511-0
피인용 문헌
- Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency vol.69, pp.2, 2020, https://doi.org/10.1016/j.alit.2019.10.011